Administration of 3% Hypertonic Saline in Suspected Encephalitis with Raised ICP and Normal Sodium
For patients with suspected encephalitis and elevated intracranial pressure (ICP), 3% hypertonic saline should be administered as a 250 ml bolus over 15-20 minutes through a peripheral IV, with repeat doses every 2-3 hours as needed, while maintaining serum sodium below 155 mmol/L and osmolarity below 320 mOsm/L. 1
Dosing Protocol
- Initial dose: 250 ml of 3% hypertonic saline administered over 15-20 minutes
- Administration route: Can be safely given through peripheral IV access 2
- Repeat dosing: Every 2-3 hours as needed for ICP control
- Maximum frequency: Average of 7 boluses in 12 hours for refractory cases 1
Monitoring Requirements
- Serum sodium: Check before each bolus and every 6 hours during treatment
- Target sodium level: Maintain below 155 mmol/L
- Serum osmolarity: Keep below 320 mOsm/L 1, 3
- ICP monitoring: Continuous monitoring during administration when possible
Safety Parameters
- Contraindications to repeat dosing: Serum sodium >155 mmol/L 3
- Administration rate: Boluses can be safely administered at rates up to 999 mL/hr without increased risk of extravasation or phlebitis 2
- Head position: Elevate head of bed to 30° to facilitate venous drainage
Indications for Use in Encephalitis
- Primary indication: Refractory intracranial hypertension (ICP >20-25 mmHg for >5 minutes)
- Secondary indication: Acute neurological deterioration with clinical signs of increased ICP 1
- Timing: Should be administered as soon as possible after lumbar puncture confirms diagnosis, unless contraindicated 3
Special Considerations
- If lumbar puncture is contraindicated due to suspected raised ICP, CT scan should be performed first, followed by hypertonic saline administration if significant brain shift is present 3
- For patients with suspected encephalitis who cannot undergo immediate lumbar puncture, hypertonic saline can be administered based on clinical signs of increased ICP
- In patients with normal sodium levels, careful monitoring is still required as sodium levels may rise quickly with repeated boluses
Efficacy and Limitations
- Hypertonic saline is effective at reducing raised ICP (Grade A evidence) but does not improve neurological outcomes (Grade B) or survival (Grade A) 3
- The treatment should be part of a comprehensive approach to managing encephalitis with raised ICP
Potential Complications
- Hypernatremia
- Hyperchloremic metabolic acidosis
- Phlebitis (though rare with proper administration)
- Central pontine myelinolysis (with very rapid sodium correction)
This protocol provides a clear approach to administering 3% hypertonic saline in suspected encephalitis with raised ICP while maintaining normal sodium levels through careful monitoring and dosing adjustments.